| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,563 |
14,158 |
$652K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,431 |
12,964 |
$579K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,419 |
11,801 |
$572K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,011 |
2,950 |
$323K |
| 80053 |
Comprehensive metabolic panel |
25,932 |
23,218 |
$223K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,884 |
5,710 |
$185K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,224 |
9,715 |
$177K |
| 97597 |
|
1,321 |
664 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,094 |
17,208 |
$70K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,394 |
3,203 |
$50K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
409 |
399 |
$37K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
644 |
640 |
$37K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
531 |
491 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,770 |
2,639 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
3,872 |
3,728 |
$28K |
| 83690 |
|
3,694 |
3,519 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,423 |
1,387 |
$17K |
| G0378 |
Hospital observation service, per hour |
425 |
285 |
$17K |
| 87081 |
|
2,040 |
2,023 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
641 |
637 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
632 |
528 |
$12K |
| 0240U |
|
123 |
121 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
164 |
109 |
$10K |
| 87632 |
|
183 |
183 |
$9K |
| 84703 |
|
1,030 |
975 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
93 |
90 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
242 |
239 |
$8K |
| 81003 |
|
6,370 |
6,082 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
110 |
107 |
$7K |
| 84439 |
|
788 |
768 |
$7K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
249 |
87 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
692 |
654 |
$6K |
| 82728 |
|
314 |
313 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
490 |
422 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
467 |
464 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
400 |
381 |
$5K |
| 80061 |
Lipid panel |
488 |
480 |
$4K |
| 85027 |
|
540 |
487 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$4K |
| 84484 |
|
397 |
368 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
482 |
476 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
76 |
74 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
74 |
72 |
$3K |
| 86885 |
|
140 |
124 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
64 |
60 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14 |
14 |
$3K |
| 85610 |
|
566 |
523 |
$3K |
| 97161 |
|
49 |
47 |
$2K |
| 87807 |
|
125 |
122 |
$2K |
| 93976 |
|
38 |
37 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
217 |
194 |
$2K |
| 85730 |
|
407 |
391 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
39 |
36 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
55 |
50 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35 |
31 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,513 |
1,415 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
243 |
203 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,059 |
1,894 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
53 |
52 |
$1K |
| 87186 |
|
126 |
114 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
120 |
119 |
$1K |
| 87634 |
|
29 |
29 |
$1K |
| 87653 |
|
24 |
24 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,269 |
1,088 |
$973.34 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
28 |
$932.84 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
20 |
15 |
$915.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15 |
13 |
$910.00 |
| 87077 |
|
126 |
114 |
$866.33 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
16 |
12 |
$866.00 |
| 83605 |
|
110 |
93 |
$800.01 |
| 83615 |
|
152 |
119 |
$774.61 |
| 36410 |
|
90 |
84 |
$669.31 |
| 86901 |
|
114 |
110 |
$661.93 |
| 83735 |
|
131 |
124 |
$627.78 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
34 |
16 |
$609.57 |
| 73630 |
|
49 |
42 |
$587.55 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
14 |
$582.65 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
15 |
15 |
$575.46 |
| 86592 |
|
83 |
83 |
$554.19 |
| 82962 |
|
106 |
73 |
$532.90 |
| 85014 |
|
318 |
314 |
$516.40 |
| 85018 |
|
302 |
301 |
$502.89 |
| 86900 |
|
107 |
104 |
$498.27 |
| 74018 |
|
44 |
39 |
$474.72 |
| 87040 |
|
57 |
43 |
$450.23 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28 |
25 |
$449.24 |
| 87210 |
|
37 |
37 |
$425.56 |
| 76937 |
|
43 |
38 |
$407.14 |
| 83880 |
|
28 |
26 |
$388.58 |
| 86140 |
|
64 |
57 |
$364.70 |
| 84702 |
|
34 |
31 |
$334.92 |
| 73110 |
|
20 |
14 |
$333.83 |
| 96376 |
|
30 |
27 |
$327.67 |
| 92081 |
|
12 |
12 |
$306.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
15 |
$303.90 |
| 85379 |
|
61 |
56 |
$302.70 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
88 |
75 |
$283.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
217 |
203 |
$281.37 |
| 73562 |
|
15 |
15 |
$275.70 |
| 83721 |
|
66 |
66 |
$252.76 |
| 82607 |
|
38 |
37 |
$250.83 |
| 82950 |
|
32 |
32 |
$245.43 |
| 87070 |
|
40 |
37 |
$245.09 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
178 |
171 |
$242.55 |
| 72100 |
|
13 |
13 |
$239.08 |
| 85007 |
|
129 |
107 |
$222.03 |
| 86850 |
|
25 |
25 |
$221.53 |
| 74019 |
|
32 |
31 |
$197.61 |
| 82803 |
|
15 |
13 |
$191.05 |
| 82746 |
|
24 |
24 |
$174.02 |
| 85049 |
|
15 |
14 |
$139.88 |
| 82565 |
|
33 |
32 |
$137.60 |
| 36415 |
Collection of venous blood by venipuncture |
6,531 |
4,626 |
$117.07 |
| 85652 |
|
30 |
26 |
$113.42 |
| 83540 |
|
26 |
26 |
$113.17 |
| 73502 |
|
13 |
12 |
$105.57 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
50 |
43 |
$98.23 |
| 84550 |
|
13 |
13 |
$81.00 |
| J2704 |
Injection, propofol, 10 mg |
158 |
118 |
$69.22 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
94 |
76 |
$68.59 |
| 82947 |
|
13 |
13 |
$64.09 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
16 |
$36.93 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15 |
15 |
$33.94 |
| J2060 |
Injection, lorazepam, 2 mg |
44 |
39 |
$32.52 |
| 82077 |
|
25 |
25 |
$31.71 |
| 81001 |
|
12 |
12 |
$29.40 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
14 |
$26.33 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13 |
12 |
$7.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
13 |
12 |
$5.47 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
234 |
219 |
$4.80 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
12 |
$2.14 |
| 90461 |
|
18 |
15 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
59 |
54 |
$0.00 |
| 90686 |
|
31 |
31 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
34 |
28 |
$0.00 |